D

    Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA)

    Official site

    FINANCIAL SERVICES • SHELL COMPANIES • NASDAQ

    $10.75
    +0.00 (+0.00%)

    Market Cap: $260.98M

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    PeriodReportedEst.SurpriseB/MYoY
    Jun 26
    		$0.06N/AN/ABeat-20.0%
    Mar 26
    		$0.06N/AN/ABeat+16.8%
    Dec 25
    		$0.01N/AN/ABeat+121.0%
    Sep 25
    		$0.07N/AN/ABeat-
    Jun 25
    		$0.07N/AN/ABeat-
    Mar 25
    		$0.05N/AN/ABeat-
    Dec 24
    		$-0.03$0.00N/AMiss-

    Key Metrics

    Valuation
    P/E Ratio57.83EV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin0.00%Operating Margin0.00%
    ROE0.00%ROIC29.48%
    Financial Health
    Debt/Equity-0.05xInterest CoverageN/A
    Current Ratio0.02xQuick Ratio0.02x
    Trading Statistics
    BetaN/AAvg Volume9.35K
    52-Week High$10.7652-Week Low$10.23

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$10.74
    SMA 20$10.73
    SMA 50$10.69
    SMA 200$10.53
    EMA 10$10.74
    EMA 20$10.73
    EMA 50$10.69
    EMA 200$10.54

    MACD

    Line: 0.02Signal: 0.02Hist: 0.00

    ADX

    ADX: 14.9+DI: 21.8-DI: 26.8

    Aroon & PSAR

    Aroon Up92.0
    Aroon Down28.0
    PSAR$10.72

    Bollinger Bands

    Upper Band$10.77
    Lower Band$10.69
    %B Position76%(Middle)
    Band Width0.78

    RSI (14-Day)

    Neutral
    69.1

    Momentum Oscillators

    Stoch %K88.9
    Stoch %D94.4
    Williams %R-16.7
    ROC (10d)0.3%
    Momentum0.03
    CCI (20d)82.9
    MFI (14d)84.7

    Volatility Measures

    ATR (14d)$0.01(0.1%)
    StdDev (20d)0.02
    Hist Vol1.2%(Low)

    Volume Flow

    VWAP$10.75
    OBV10.5M
    AD Line7.4M
    CMF (20d)0.724

    Volume Metrics

    Avg Vol (20d)9.8K
    Vol Ratio0.4x(Low)
    VWMA (20d)$10.75

    Pivot Points

    R3$10.76
    R2$10.76
    R1$10.75
    Pivot Point$10.75
    S1$10.74
    S2$10.74
    S3$10.73

    Advanced Oscillators

    TSI46.13
    Ultimate Osc75.6
    KST4.75

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
    Total Revenue$0$0$0$0$0$0N/A$0N/A
    Cost of Revenue$0$0N/A$0$0$0N/A$0N/A
    Gross Profit$0$0N/A$0$0$0N/A$0N/A
    Operating Expenses$136,934$143,301$2.09M$263,703$131,919$330,925N/A$144,928N/A
    R&D$0$0$0$0$0$0$0$0$0
    SG&A$136,934$143,301$2.09M$263,703$131,919$330,925$0$144,928$0
    Operating Income$-136,934$-143,301$-2,089,466$-263,703$-131,919$-330,925$-279$-144,928N/A
    Interest Income$1.86M$2.11M$2.30M$2.45M$2.42M$1.59M$0$0$0
    Interest Expense$0$0$0$0$0$0$0$0$0
    Income Before Tax$1.73M$1.97M$212,958$2.18M$2.29M$1.25M$-279$-144,928$0
    Income Tax Expense$0$0$0$0$0$0$0$0$0
    Net Income$1.73M$1.97M$212,958$2.18M$2.29M$1.25M$-279$-144,928N/A
    EBITDA$-136,934$-143,301$-2,089,466$-263,703$-131,919$-330,925$-79,986$-144,928$-54,931
    EBIT$-136,934$-143,301$-2,089,466$-263,703$-131,919$-330,925N/A$-144,928N/A
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about DMAA

    News

    Drugs Made In America Acquisition Corp. Revenue Breakdown – BOATS:DMAAU

    This article provides a financial overview of Drugs Made In America Acquisition Corp. (DMAAU) as presented on TradingView. It indicates that the market is closed for this stock with no recent trades. The page offers access to financial statements, statistics, dividends, earnings, and segment performance data for the company.

    TradingView•8/4/26•
    Neutral

    Drugs Made In America Acquisition Corp. Revenue Breakdown – BOATS:DMAAR

    This page provides financial data and an overview for Drugs Made In America Acquisition Corp. (DMAAR) on TradingView. It indicates that the market is closed, with no current trades. Users can find fundamentals, statistics, dividend information, earnings, and segment performance for the company.

    TradingView•8/3/26•
    Neutral

    Drugs Made In America Acquisition II Corp. Revenue Breakdown – BOATS:DMIIU

    This article provides a brief overview of Drugs Made In America Acquisition II Corp. (DMIIU) financial information available on TradingView. It indicates that the market is closed and there are no trades for the company. The page focuses on fundamental data, statements, statistics, dividends, earnings, and segment performance.

    TradingView•8/2/26•
    Neutral

    Drugs Made In America Acquisition Corp (DMAA) Dividends & Stock Splits: Historical Payouts and Event Timeline

    This article provides details on the dividend and stock split history for Drugs Made In America Acquisition Corp (DMAA). It notes that no dividends have been distributed over the past five years. The page also displays current stock information, including its price, market cap, and P/E ratio.

    TradingKey•7/27/26•
    Neutral

    Drugs Made In America Acquisition Corp (DMAA) Valuation: PE, PB & Fair Value Analysis

    This article provides a valuation analysis for Drugs Made In America Acquisition Corp (DMAA), focusing on its P/E ratio, P/B ratio, and fair value. As of July 24th, DMAA's stock was trading at $10.709 with a market cap of $361.09 million and a TTM P/E of 74.29.

    TradingKey•7/27/26•
    Neutral

    Frequently Asked Questions About DMAA

    Does DMAA pay dividends?
    Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) does not currently pay a regular dividend.
    What is DMAA's P/E ratio?
    Drugs Made In America Acquisition Corp. Ordinary Shares has a price-to-earnings (P/E) ratio of 57.83.
    What is DMAA's market cap?
    Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) has a market capitalization of $260.98M with a current stock price of $10.75.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In